Skip to main content
. Author manuscript; available in PMC: 2024 Jun 12.
Published in final edited form as: Biol Blood Marrow Transplant. 2020 Jun 4;26(9):1704–1710. doi: 10.1016/j.bbmt.2020.05.019

Figure 4.

Figure 4.

(A) Species abundance at baseline (before the start of the transplantation chemotherapy regimen in the SOC and xylitol groups. (B) (1) Increased pathogenic species abundance at baseline and days 7, 14, 28 post-transplantation in the SOC group compared with the xylitol group. (2) Increased Streptococcus spp abundance (oral pathogenic bacteria) at day 7 post-transplantation in the SOC group compared with the xylitol group. (3) Increased fungal species abundance at days 7, 14, and 28 post-transplantation in the SOC group compared with the Xylitol group.